Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 47Terminated 14Unknown 3Withdrawn 2Active not recruiting 2Suspended 1Recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Non-Small-Cell Lung 42Lung Neoplasms 13Neoplasms 7Brain Neoplasms 6Pancreatic Neoplasms 3Neoplasm Metastasis 3NSCLC 3Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Central Nervous System Neoplasms 2Breast Neoplasms 2Adenocarcinoma, Bronchiolo-Alveolar 2Adenocarcinoma of Lung 2Tongue Neoplasms 1Thoracic Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Respiratory Tract Diseases 1Relapsed Pediatric Solid Tumor 1Recurrence 1Precancerous Conditions 1Optic Nerve Glioma 1Non-squamous Non-small Cell Lung Cancer 1Metastatic Pancreatic Adenocarcinoma 1Medulloblastoma 1Lung Diseases 1Head and Neck Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Familial ependymoma 1

Interventions

Gemcitabine 78Fluorouracil 27Oxaliplatin 24130-nm albumin-bound paclitaxel 24Leucovorin 18Capecitabine 15Albumin-Bound Paclitaxel 15S 1 (combination) 14Taxes 12Irinotecan 11pembrolizumab 9folfirinox 9Radiosurgery 9Radiotherapy 7Drug Therapy 7Cisplatin 7irinotecan sucrosofate 6Pancreaticoduodenectomy 5Paclitaxel 5Injections 5Docetaxel 5Blood Specimen Collection 5apatinib 4Radiofrequency Ablation 4Radiation 4Biopsy 4tislelizumab 3rubitecan 3nimotuzumab 3camrelizumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Pancreatic Neoplasms × Erlotinib Hydrochloride × Clear all
NCT02737228 2019-06-17

Study of CG200745 PPA in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer

CrystalGenomics, Inc.

Phase 1/2 Unknown
24 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01608841 2015-02-18

The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib

Taipei Veterans General Hospital, Taiwan

Phase 2 Unknown
88 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT00440167 2012-07-09

Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine

Ludwig-Maximilians - University of Munich

Phase 3 Unknown
280 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡